Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

Inclusion Criteria: * Healthy volunteers * BMI between 18 and 30 kg/m2 * Body weight: Male≥50kg, Female≥45kg * Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study Exclusion Criteria: * Subjects with allergy or drug hypersensitivity * Subjects with clinically significant medical history * Subjects with history of drug abuse or addicted